Mobile Apps for Heart Rate Variability: App Store Search and Content Analysis

Clinical Snapshot

Key Findings

• P Value: Not applicable — descriptive study; no inferential statistics reported in abstract

• Effect Size: Photoplethysmography was the most common sensing modality (n=117, 56.8%); 81.7% of fully extractable apps (76/93) presented personalised trends or individualised ranges; 86% (80/93) offered contextual guidance such as readiness or recovery scores. RMSSD was the most commonly reported HRV metric (n=51), followed by SDNN (n=48).

• Primary Outcome: Of 746 apps identified, 206 met eligibility criteria. Apps were categorised as primary measurement (n=132, 64.1%), aggregators (n=59, 28.6%), or hybrid (n=15, 7.3%). Full content analysis was achievable for only 93 apps (45.1%), representing the transparent subset.

• Nnt Or Sensitivity: Not applicable for this descriptive content analysis. Key transparency metric: only 45.1% of eligible apps provided sufficient information for full data extraction, indicating a majority transparency failure rate of 54.9%.

• Confidence Interval: Not reported

Clinical Application

The findings directly inform clinical guidance on app selection. The low transparency rate (54.9% of apps lacking sufficient information for evaluation) suggests clinicians should exercise caution when recommending consumer HRV apps. Apps that disclose their HRV metrics (particularly RMSSD and SDNN), sensor validation, and algorithmic methodology should be preferred. Proprietary 'readiness' or 'recovery' scores without disclosed derivation methods cannot be independently validated and should be interpreted with caution in clinical contexts. In Australia, the Therapeutic Goods Administration (TGA) regulates Software as a Medical Device (SaMD) under the Medical Devices Regulations 2002. Consumer HRV apps that make diagnostic or therapeutic claims may require TGA registration, yet the majority of apps in this study appear to operate in a regulatory grey zone by framing outputs as 'wellness' rather than medical information. The RACGP does not currently have specific guidelines for HRV app recommendation in primary care. Clinicians should be aware that most consumer HRV apps are not TGA-listed medical devices and lack the evidentiary standards required for clinical decision-making. The Australian Digital Health Agency's Framework for Action on Digital Health may provide relevant guidance for clinicians navigating this landscape. PBS listing is not applicable to mobile applications. Clinicians, researchers, and health consumers considering the use of consumer HRV mobile applications for health monitoring, athletic performance, stress management, or autonomic nervous system assessment outside laboratory settings

Abstract

BACKGROUND: Heart rate variability (HRV) is a noninvasive indicator of autonomic nervous system activity that is increasingly used for health and performance monitoring. Digital and mobile technologies are increasingly providing opportunities for remote HRV monitoring outside of laboratory-based settings. OBJECTIVE: This study aimed to describe the landscape of mobile apps that measure, analyze, and provide feedback on HRV, with a focus on how HRV is measured, analyzed, interpreted, and communicated to users. A secondary aim was to assess the transparency of these apps, including the extent to which they disclose the evidence underpinning their HRV metrics and feedback. METHODS: This study was an app store search and content analysis. Searches were conducted in the Google Play Store and Apple iTunes Store. Apps were eligible for inclusion if they had functionality to record, analyze, or provide feedback on HRV and were available in English. Data were extracted from app descriptions, screenshots, websites, and, where necessary, contact with developers. Data were extracted on app metadata (developer, release and update dates, and pricing), alongside information about HRV measurement, analysis, and feedback. This included the type of sensor used; HRV measurement characteristics (sensor placement, recording duration, and body position or standardization procedures); methods to calculate and interpret HRV (ie, metrics derived and how they were interpreted for users); and additional app functionality such as reminders, the ability to log self-reported stressors, and the type of feedback or guidance provided based on HRV. We used previously published criteria for assessing the quality of information on the internet, which included authorship, scientific attribution, currency of updates, and data privacy. RESULTS: Of 746 apps identified, 206 met eligibility criteria. Of these, 132 were primary measurement apps, 59 were aggregators, and 15 were hybrid. Photoplethysmogram was the most common sensing modality (n=117, 56.8%), followed by multiple sensors (n=60, 29.1%). Full data extraction across app metadata and HRV measurement and analysis data was only achievable for 93 (45.1%) apps, representing a transparent subset with sufficient available information for content analysis. The most commonly reported HRV metrics were root mean square of successive differences (n=51) and SD of normal-to-normal intervals (n=48), while frequency-domain power (n=22) and low frequency to high frequency ratios (n=15) were less common. Most apps presented data as personalized trends or individualized ranges (76/93, 81.7%), emphasizing user-specific context rather than isolated values. Although 86% (80/93) offered contextual guidance (eg, readiness or recovery scores), many relied on proprietary algorithms that were not transparently described, limiting independent assessment of how these scores were derived and validated. CONCLUSIONS: Consumer HRV apps are widely available but vary considerably in how data are collected, processed, and contextualized. While many offer personalized trends and guidance, methodological transparency is often limited, particularly regarding the proprietary algorithms underlying the feedback scores.

References

1. 1.de Jager, E., Caulfield, B., Angelidi, E., & Holden, S. (2026). Mobile apps for heart rate variability: App store search and content analysis. JMIR Cardio. https://doi.org/10.1109/EuroSPW59978.2023.00022